328 related articles for article (PubMed ID: 9744794)
21. Tau-based treatment strategies in neurodegenerative diseases.
Schneider A; Mandelkow E
Neurotherapeutics; 2008 Jul; 5(3):443-57. PubMed ID: 18625456
[TBL] [Abstract][Full Text] [Related]
22. Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease.
Botez G; Probst A; Ipsen S; Tolnay M
Acta Neuropathol; 1999 Sep; 98(3):251-6. PubMed ID: 10483782
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylated serine422 on tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration.
Bussière T; Hof PR; Mailliot C; Brown CD; Caillet-Boudin ML; Perl DP; Buée L; Delacourte A
Acta Neuropathol; 1999 Mar; 97(3):221-30. PubMed ID: 10090668
[TBL] [Abstract][Full Text] [Related]
24. Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy.
Arai T; Ikeda K; Akiyama H; Shikamoto Y; Tsuchiya K; Yagishita S; Beach T; Rogers J; Schwab C; McGeer PL
Acta Neuropathol; 2001 Feb; 101(2):167-73. PubMed ID: 11271372
[TBL] [Abstract][Full Text] [Related]
25. Tau epitope display in progressive supranuclear palsy and corticobasal degeneration.
Berry RW; Sweet AP; Clark FA; Lagalwar S; Lapin BR; Wang T; Topgi S; Guillozet-Bongaarts AL; Cochran EJ; Bigio EH; Binder LI
J Neurocytol; 2004 May; 33(3):287-95. PubMed ID: 15475684
[TBL] [Abstract][Full Text] [Related]
26. The Role of Tau Proteoforms in Health and Disease.
Waheed Z; Choudhary J; Jatala FH; Fatimah ; Noor A; Zerr I; Zafar S
Mol Neurobiol; 2023 Sep; 60(9):5155-5166. PubMed ID: 37266762
[TBL] [Abstract][Full Text] [Related]
27. Exon 3 insert of tau protein in neurodegenerative diseases.
Terada S; Ishizu H; Ishiguro K; Tanabe Y; Itoh N; Yasutake K; Furubayashi A; Kitamura Y; Kuroda S
Acta Neuropathol; 2005 Jul; 110(1):12-8. PubMed ID: 15918074
[TBL] [Abstract][Full Text] [Related]
28. Differential incorporation of tau isoforms in Alzheimer's disease.
Espinoza M; de Silva R; Dickson DW; Davies P
J Alzheimers Dis; 2008 May; 14(1):1-16. PubMed ID: 18525123
[TBL] [Abstract][Full Text] [Related]
29. Association of CD2AP neuronal deposits with Braak neurofibrillary stage in Alzheimer's disease.
Camacho J; Rábano A; Marazuela P; Bonaterra-Pastra A; Serna G; Moliné T; Ramón Y Cajal S; Martínez-Sáez E; Hernández-Guillamon M
Brain Pathol; 2022 Jan; 32(1):e13016. PubMed ID: 34514662
[TBL] [Abstract][Full Text] [Related]
30. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
31. [Neuropathology of tauopathy].
Yoshida M
Brain Nerve; 2013 Dec; 65(12):1445-58. PubMed ID: 24323931
[TBL] [Abstract][Full Text] [Related]
32. Assembly of filamentous tau aggregates in human neuronal cells.
Ko LW; Rush T; Sahara N; Kersh JS; Easson C; Deture M; Lin WL; Connor YD; Yen SH
J Alzheimers Dis; 2004 Dec; 6(6):605-22; discussion 673-81. PubMed ID: 15665401
[TBL] [Abstract][Full Text] [Related]
33. [Tau protein abnormality and dementia: the mechanisms of neurodegeneration].
Tanaka T; Takeda M
No To Shinkei; 2002 Sep; 54(9):777-87. PubMed ID: 12428364
[No Abstract] [Full Text] [Related]
34. Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration.
Feany MB; Mattiace LA; Dickson DW
J Neuropathol Exp Neurol; 1996 Jan; 55(1):53-67. PubMed ID: 8558172
[TBL] [Abstract][Full Text] [Related]
35. Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease.
Goedert M; Spillantini MG
Biochim Biophys Acta; 2000 Jul; 1502(1):110-21. PubMed ID: 10899436
[TBL] [Abstract][Full Text] [Related]
36. Structure of NFT: Biochemical Approach.
Hasegawa M
Adv Exp Med Biol; 2019; 1184():23-34. PubMed ID: 32096025
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylated c-MYC expression in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Blanco R; Carmona M; Puig B
Neuropathol Appl Neurobiol; 2001 Oct; 27(5):343-51. PubMed ID: 11679086
[TBL] [Abstract][Full Text] [Related]
38. Pathological Tau proteins of Alzheimer's disease as a biochemical marker of neurofibrillary degeneration.
Delacourte A
Biomed Pharmacother; 1994; 48(7):287-95. PubMed ID: 7858159
[TBL] [Abstract][Full Text] [Related]
39. An autoradiographic evaluation of AV-1451 Tau PET in dementia.
Lowe VJ; Curran G; Fang P; Liesinger AM; Josephs KA; Parisi JE; Kantarci K; Boeve BF; Pandey MK; Bruinsma T; Knopman DS; Jones DT; Petrucelli L; Cook CN; Graff-Radford NR; Dickson DW; Petersen RC; Jack CR; Murray ME
Acta Neuropathol Commun; 2016 Jun; 4(1):58. PubMed ID: 27296779
[TBL] [Abstract][Full Text] [Related]
40. [Characterization of glial fibrillary tangles in progressive supranuclear palsy and Alzheimer's disease].
Nishimura M
No To Shinkei; 1996 Oct; 48(10):895-903. PubMed ID: 8921528
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
